1. Home
  2. LEGN vs CAR Comparison

LEGN vs CAR Comparison

Compare LEGN & CAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • CAR
  • Stock Information
  • Founded
  • LEGN 2014
  • CAR 1946
  • Country
  • LEGN United States
  • CAR United States
  • Employees
  • LEGN N/A
  • CAR N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • CAR Rental/Leasing Companies
  • Sector
  • LEGN Health Care
  • CAR Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • CAR Nasdaq
  • Market Cap
  • LEGN 5.4B
  • CAR 4.7B
  • IPO Year
  • LEGN 2020
  • CAR N/A
  • Fundamental
  • Price
  • LEGN $35.56
  • CAR $155.49
  • Analyst Decision
  • LEGN Strong Buy
  • CAR Hold
  • Analyst Count
  • LEGN 10
  • CAR 6
  • Target Price
  • LEGN $73.67
  • CAR $143.80
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • CAR 1.3M
  • Earning Date
  • LEGN 08-11-2025
  • CAR 07-29-2025
  • Dividend Yield
  • LEGN N/A
  • CAR N/A
  • EPS Growth
  • LEGN N/A
  • CAR N/A
  • EPS
  • LEGN N/A
  • CAR N/A
  • Revenue
  • LEGN $796,838,000.00
  • CAR $11,659,000,000.00
  • Revenue This Year
  • LEGN $66.76
  • CAR N/A
  • Revenue Next Year
  • LEGN $52.58
  • CAR $2.22
  • P/E Ratio
  • LEGN N/A
  • CAR N/A
  • Revenue Growth
  • LEGN 74.75
  • CAR N/A
  • 52 Week Low
  • LEGN $27.34
  • CAR $54.03
  • 52 Week High
  • LEGN $59.62
  • CAR $212.81
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 35.54
  • CAR 42.27
  • Support Level
  • LEGN $35.10
  • CAR $144.72
  • Resistance Level
  • LEGN $38.35
  • CAR $167.07
  • Average True Range (ATR)
  • LEGN 1.31
  • CAR 5.67
  • MACD
  • LEGN -0.37
  • CAR -1.33
  • Stochastic Oscillator
  • LEGN 11.33
  • CAR 48.19

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About CAR Avis Budget Group Inc.

Avis Budget Group Inc is a provider of automotive vehicle rental and car-sharing services. Its brands include Avis, Budget, and Zipcar. Avis is targeted to serve the premium commercial and leisure segments of the travel industry, while Budget is focused on value-conscious customers. The company operates its own network of rental locations and licenses its brands to franchisees. Zipcar is a car-sharing service that allows members to use the company-owned Zipcar fleet at an hourly rate. The company's largest region by revenue is the Americas.

Share on Social Networks: